Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

[1]  L. Mucke,et al.  Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice , 1994, Brain Research.

[2]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[3]  Y. Ihara,et al.  Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. , 1994, The Journal of biological chemistry.

[4]  D. Holtzman,et al.  Transgenic mouse brain histopathology resembles early Alzheimer's disease , 1994, Annals of neurology.

[5]  J. Hardy.  Alzheimer's disease. Clinical molecular genetics. , 1994, Clinics in geriatric medicine.

[6]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.

[7]  T. Choi,et al.  Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Deerinck,et al.  Re‐Evaluation of the Structural Organization of Neuritic Plaques in Alzheimer's Disease , 1993 .

[9]  D. Price,et al.  Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice , 1993, Nature Genetics.

[10]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[11]  I. Lieberburg,et al.  Lack of alzheimer pathology after β-amyloid protein injections in rat brain , 1992, Neurobiology of Aging.

[12]  H. Vinters,et al.  Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Selkoe,et al.  Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Zain,et al.  Expression of the human beta-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice. , 1991, The Journal of biological chemistry.

[15]  B. Ghetti,et al.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.

[16]  K. Murakami,et al.  Formation of β-amyloid protein deposits in brains of transgenic mice , 1991, Nature.

[17]  D. Bonthron,et al.  PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model , 1991, Cell.

[18]  E. Masliah,et al.  Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. , 1991, The American journal of pathology.

[19]  R. Neve,et al.  The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. , 1990, The Journal of biological chemistry.

[20]  J. Trojanowski,et al.  Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. V. Doyle,et al.  Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Price,et al.  Neurofibrillary Tangles and Senile Plaques in Aged Bears , 1988, Journal of neuropathology and experimental neurology.

[23]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[24]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .